Boston Scientific’s (NYSE:BSX) lead-free S-ICD cardiac rhythm management made another strong showing, with results from an analysis of more than 880 patients showing relatively few complications.
HRS 2014
HRS2014: Devices combat drugs for treatment of AF stroke-risk patients
New clinical data continues to suggest that left atrial appendage occlusion devices may pose an improvement over warfarin drug regimens for treating patients at increased risk of stroke, researchers reported today.
HRS14: St. Jude’s quadripolar pacing wins in 1st head-to-head study
The view from HRS 2014: This week at the Heart Rhythm Society’s 35th Annual Scientific Sessions
Things are still pretty quiet on opening day of Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions in semi-sunny San Francisco, but the week is shaping up to be a busy one.
There are few major announcements expected from this year’s sessions, but attendees are looking forward to some important updates on key new technologies and trends in cardiac pacing and electrophysiology, coming from the biggest players in the market.